Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04454645
Other study ID # mABC
Secondary ID 1R01HD098525-01A
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2020
Est. completion date March 31, 2026

Study information

Verified date March 2023
Source University of Delaware
Contact Mary Dozier, Ph.D.
Phone 3028312286
Email mdozier@udel.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will assess the efficacy of the modified Attachment and Biobehavioral Catch-Up (mABC) Intervention, adapted for use with peripartum mothers receiving medication-assisted treatment for opioid use disorder. The investigators expect that mothers who receive the modified Attachment and Biobehavioral Catch-up Intervention will show more nurturing and sensitive parenting and more adaptive physiological regulation than parents who receive a control intervention. The investigators expect that infants whose mothers receive the modified Attachment and Biobehavioral Catch-up will show better outcomes in attachment, behavior, and physiological regulation than infants of parents who receive the control intervention.


Description:

Pregnant mothers will be randomly assigned to receive the modified ABC intervention or the control intervention (modified DEF). Hypotheses relate to parent and child outcomes associated with the intervention. Hypothesis 1: Compared to mothers who receive the control intervention, mothers who receive the mABC intervention will show more nurturing and sensitive parenting, enhanced neural activity during parenting-relevant tasks, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 2: Compared to infants of mothers who receive the control intervention, infants of mothers who receive the mABC intervention will show more organized and secure attachment patterns, better behavioral regulation during stressors, more advanced social-emotional development, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 3: Enhanced maternal sensitivity will mediate effects of the mABC intervention on improved infant outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date March 31, 2026
Est. primary completion date March 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Opioid-dependent pregnant women in third trimester of pregnancy on medication-assisted treatment Exclusion Criteria: - None

Study Design


Intervention

Behavioral:
mABC
Intervention targets parenting sensitivity and nurturance.
mDEF
Intervention targets parenting enhancing infant cognitive development

Locations

Country Name City State
United States University of Delaware Newark Delaware

Sponsors (2)

Lead Sponsor Collaborator
University of Delaware Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal sensitivity The mother will be assessed interacting with the infant simulator. Parental sensitivity (a composite of following the child's lead in interactions, providing nurturance when the child is distressed, and showing positive regard) will be assessed using procedures and coding from the assessment used by the NICHD Study of Early Child Care and Youth Development (Brady-Smith et al., 1999). Sensitivity will be assessed on a 5-point scale with higher scores indicating greater sensitivity. Pre-intervention (3rd trimester)
Primary Maternal sensitivity The mother will be assessed interacting one-to-one with her infant. Parental sensitivity (a composite of following the child's lead in interactions, providing nurturance when the child is distressed, and showing positive regard) will be assessed using procedures and coding from the assessment used by the NICHD Study of Early Child Care and Youth Development (Brady-Smith et al., 1999). Sensitivity will be assessed on a 5-point scale with higher scores indicating greater sensitivity. Infant age of 3 months
Primary Maternal sensitivity The mother will be assessed interacting one-to-one with her infant. Parental sensitivity (a composite of following the child's lead in interactions, providing nurturance when the child is distressed, and showing positive regard) will be assessed using procedures and coding from the assessment used by the NICHD Study of Early Child Care and Youth Development (Brady-Smith et al., 1999). Sensitivity will be assessed on a 5-point scale with higher scores indicating greater sensitivity. Infant age of 6 months
Primary Maternal sensitivity The mother will be assessed interacting one-to-one with her infant. Parental sensitivity (a composite of following the child's lead in interactions, providing nurturance when the child is distressed, and showing positive regard) will be assessed using procedures and coding from the assessment used by the NICHD Study of Early Child Care and Youth Development (Brady-Smith et al., 1999). Sensitivity will be assessed on a 5-point scale with higher scores indicating greater sensitivity. Infant age of 12 months
Primary Maternal methylation of µ-opioid receptor (OPRM1) gene Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva Pre-intervention (3rd trimester)
Primary Maternal methylation of µ-opioid receptor (OPRM1) gene Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva Infant age of 12 months
Primary Maternal methylation of oxytocin receptor (OXTR) gene Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva Pre-intervention (3rd trimester)
Primary Maternal methylation of oxytocin receptor (OXTR) gene Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva Infant age of 12 months
Primary Infant methylation of µ-opioid receptor (OPRM1) gene Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva Pre-intervention (3rd trimester)
Primary Infant methylation of µ-opioid receptor (OPRM1) gene Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva Infant age of 12 months
Primary Maternal neural activity (Event related potentials - ERP) - Own child-other child task Maternal event-related potentials (ERP) will be assessed while viewing photos of their own infants, familiar infants, and unfamiliar infants. The P300 (a positive deflection about 300 ms after the stimuli) will be studied, with a bigger difference between own and other child considered preferable. Pre-intervention (3rd trimester)
Primary Maternal neural activity (Event related potentials - ERP) - Own child-other child task Maternal event-related potentials will be assessed while viewing photos of their own infants, familiar infants, and unfamiliar infants. The P300 (a positive deflection about 300 ms after the stimuli) will be studied, with a bigger difference between own and other child considered preferable. Infant age of 12 months
Primary Maternal neural activity (Event related potentials - ERP) - Reward sensitivity task Maternal event-related potentials will be assessed while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images. The P300 (a positive deflection about 300 ms after the stimuli) will be studied, with a bigger difference between child and opioid-related images considered preferable. Pre-intervention (3rd trimester)
Primary Maternal neural activity (Event related potentials - ERP) - Reward sensitivity task Maternal event-related potentials will be assessed while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images. The P300 (a positive deflection about 300 ms after the stimuli) will be studied, with a bigger difference between child and opioid-related images considered preferable. Infant age of 12 months
Primary Maternal neural activity (Event related potentials - ERP) - Child emotion task Maternal event-related potentials will be assessed while viewing images of children crying, laughing, and showing neutral expressions. The N180 (a negative deflection about 180 ms after the stimuli) will be studied, with a bigger difference between faces will be considered preferable. Pre-intervention (3rd trimester)
Primary Maternal neural activity (Event related potentials - ERP) - Child emotion task Maternal event-related potentials will be assessed while viewing images of children crying, laughing, and showing neutral expressions. The N180 (a negative deflection about 180 ms after the stimuli) will be studied, with a bigger difference between faces will be considered preferable. Infant age of 12 months
Primary Maternal parasympathetic nervous system activity during Still Face The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable. Pre-intervention (3rd trimester)
Primary Maternal parasympathetic nervous system activity The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable. Infant age of 12 months
Primary Infant parasympathetic nervous system activity The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable. Infant age of 6 months
Primary Infant parasympathetic nervous system activity The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable. Infant age of 12 months
Primary Infant diurnal cortisol production Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at waketime and bed-time. Infant age of 6 months
Primary Infant diurnal cortisol production Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at waketime and bed-time. Infant age of 12 months
Primary Infant behavioral regulation Behavioral coding of emotion regulation will be conducted from video recordings of the Still Face Paradigm on the Behavioral Regulation Scale, a mild social stressor. Behavior regulation will be coded on a scale called Behavior Regulation. The scores will be continuous with higher scores indicating better regulation (ranging from 1-9). Infant age of 6 months
Primary Infant behavioral regulation Behavioral coding of emotion regulation will be conducted from video recordings of the Still Face Paradigm on the Behavioral Regulation Scale, a mild social stressor. Behavior regulation will be coded on a scale called Behavior Regulation. The scores will be continuous with higher scores indicating better regulation (ranging from 1-9). Infant age of 12 months
Primary Infant attachment Infant attachment will be assessed using the Strange Situation. Coding will be completed using the standard Strange Situation coding scheme (with 4 major categories, with secure preferable). Infant age of 12 months
Primary Infant cognitive development Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire. Scores could range from 0-300 with higher scores reflecting higher functioning. Infant age of 12 months
Secondary Maternal substance use Mothers will report on substance use through the Timeline Follow-Back Interview. Higher scores will reflect more use of illicit substances (score from 0-unlimited). Pre-intervention (3rd trimester)
Secondary Maternal substance use Mothers will report on substance use through the Timeline Follow-Back Interview. Higher scores will reflect more use of illicit substances (score from 0-unlimited). Infant age of 12 months
Secondary Maternal depression Mothers will report on their depression on the Beck Depression Inventory - II, with higher scores indicating more depressive symptoms reported. (Scores could range from 0-63.) Pre-intervention (3rd trimester)
Secondary Maternal depression Mothers will report on their depression on the Beck Depression Inventory - II, with higher scores indicating more depressive symptoms reported. (Scores could range from 0-63.) Infant age of 12 months
Secondary Maternal executive functioning Mothers will complete Flanker task. Scores have a mean of 100 with a standard deviation of 15, with higher scores reflecting stronger executive functioning. Pre-intervention (3rd trimester)
Secondary Maternal executive functioning Mothers will complete Flanker task. Scores have a mean of 100 with a standard deviation of 15, with higher scores reflecting stronger executive functioning. Infant age of 12 months
See also
  Status Clinical Trial Phase
Completed NCT03905278 - Parental Support Intervention in the Oncological Context N/A
Recruiting NCT06111040 - Nurturing Needs Study: Parenting Food Motivated Children N/A
Completed NCT03559907 - Partnering for Prevention: Building Healthy Habits in Underserved Communities N/A
Completed NCT04628546 - The Parenting Young Children Check-up Evaluation N/A
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04502979 - Learning to Love Mealtime Together N/A
Completed NCT03097991 - Randomized Controlled Trial of Prenatal Coparenting Intervention (CoparentRCT) N/A
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT04556331 - Sowing the Seeds of Confidence: Brief Online Group Parenting Programme for Anxious Parents of 1-3 Year Olds N/A
Completed NCT04101799 - Evaluation of the Parental Support Intervention For Our Children's Sake in Prisons in Sweden N/A
Completed NCT02792309 - Impact Evaluation of MotherWise Program N/A
Recruiting NCT02622048 - Understanding and Helping Families: Parents With Psychosis N/A
Completed NCT02718508 - An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use N/A
Completed NCT01861158 - Online Parent Training for Children With Behavior Disorders N/A
Completed NCT01554215 - Mom Power is an Attachment Based Parenting Program for Families and Their Children Phase 2
Terminated NCT01395238 - Enhancing Father's Ability to Support Their Preschool Child N/A
Completed NCT05930535 - Family-Focused Adolescent & Lifelong Health Promotion N/A
Completed NCT04525703 - Pathways for Parents After Incarceration Feasibility Study N/A
Recruiting NCT06038799 - Caregiver Skills Training: Comparing Clinician Training Methods N/A